INTRAPERITONEAL (IP) CISPLATIN (P) VERSUS NO FURTHER TREATMENT: 8 YEAR-RESULTS OF AN EORTCGCG RANDOMIZED PHASE III STUDY IN OVARIAN CANCER (O.C.) PATIENTS (PTS) WITH A PATHOLOGICALLY COMPLETE REMISSION (PCR) AFTER P-BASED INDUCTION CHEMOTHERAPY (CT) AND CYTOREDUCTIVE SURGERY. Issue 1 (1st March 2003) - Piccart, M. J.; Floquet, A.; Scarfone, G.; Willemse, P. H.B.; Kobierska, A.; Chevallier, B.; Awada, A.; Vergote, I.; Giurgea, L.; Coens, C.; Vermorken, J.